{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:35:18Z","timestamp":1787758518455,"version":"build-2784847793"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Cervical cancer ranks as the second most common cancer in women in India, primarily caused by persistent infection with the human papillomavirus (HPV). Given its long latent period, secondary prevention through screening and early detection is essential. However, fear and stigma associated with cancers and the costs involved in disease management are the prominent barriers to its uptake. HPV vaccination is one of the vital components of the World Health Organization\u2019s (WHO) Global Strategy to speed up the elimination of cervical cancer as a public health problem. In India, four prophylactic HPV vaccines are currently available. These vaccines are non-infective and highly immunogenic, safe, and effective when administered before HPV exposure. According to WHO recommendations, the primary target group for HPV vaccination consists of girls between the ages of 9 and 14 years. Further, studies have confirmed that both single-dose and two-dose schedules of the HPV vaccine offer comparable efficacy and protection. HPV vaccines are administered intramuscularly in the deltoid region, with 0.5 ml as the standard dose. These vaccines may cause local reactions, as well as mild systemic reactions, such as headache and myalgia, but they are transient. Implementing catch-up vaccination for adolescent girls aged between 9 and 14 years at the time of HPV vaccine introduction would be a cost-effective and sustainable strategy. This would serve as a crucial component of public health efforts to manage HPV infections and eliminate cervical cancer in India.<\/jats:p>","DOI":"10.4103\/ijcm.ijcm_738_24","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T07:00:09Z","timestamp":1735542009000},"page":"S125-S131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["IAPSM\u2019s Position Paper on the Human Papilloma Virus (HPV) Vaccine for Adult Immunization in India"],"prefix":"10.4103","volume":"49","author":[{"given":"Ranjitha S.","family":"Shetty","sequence":"first","affiliation":[{"name":"Centre for Community Oncology, Department of Community Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Nadda","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr. B R Ambedkar State Institute of Medical Sciences, Mohali, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidhar","family":"Tambe","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, B. J. Government Medical College, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Raut","sequence":"additional","affiliation":[{"name":"Dr. Sushila Nayar School of Public Health (Incorporating the Department of Community Medicine), Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chythra R.","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aprajita","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Community and Family Medicine, School of Public Health, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena G","family":"Kamath","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1057\/jphp.2013.4","article-title":"Does India need an indigenous HPV vaccine and why?","volume":"34","author":"Bharati","year":"2013","journal-title":"J Public Health Policy"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3332\/ecancer.2022.1444","article-title":"Epidemiology of human papillomavirus related cancers in India: Findings from the National Cancer Registry Programme","volume":"16","author":"Ramamoorthy","year":"2022","journal-title":"Ecancermedicalscience"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R6-20260423","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R7-20260423","first-page":"27","article-title":"Human papillomavirus genotype distribution in cervical cancer in India: Results from a multicenter study","volume":"10","author":"Basu","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12879-016-2136-4","article-title":"HPV genotypes distribution in Indian women with and without cervical carcinoma: implication for HPV vaccination program in Odisha, Eastern India","volume":"17","author":"Senapati","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(10)61152-X","article-title":"Expansion of cancer care and control in countries of low and middle income: A call to action","volume":"376","author":"Farmer","year":"2010","journal-title":"Lancet"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/0976-9668.159993","article-title":"Knowledge, attitude, and practices related to cervical cancer among adult women: A hospital-based cross-sectional study","volume":"6","author":"Bansal","year":"2015","journal-title":"J Nat Sci Biol Med"},{"key":"R12-20260423","first-page":"214","article-title":"Female genital mutilation\/cutting (FGM\/C) in India: A systematic review of evidence","volume":"44","author":"Khandewal","year":"2018","journal-title":"BMJ Sex Reprod Health"},{"key":"R13-20260423","first-page":"291","article-title":"Knowledge, attitude, and practice of cervical cancer and its screening among women in Hyderabad, India","volume":"38","author":"Gupta","year":"2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","article-title":"Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women","volume":"95","author":"Strickler","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"851367","DOI":"10.3389\/fonc.2022.851367","article-title":"Artificial intelligence in cervical cancer screening and diagnosis","volume":"12","author":"Hou","year":"2022","journal-title":"Front Oncol"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40944-016-0045-5","article-title":"Community prevalence of human papillomavirus by self-collected samples in south India","volume":"14","author":"Peedicayil","year":"2016","journal-title":"Indian J Gynecol Oncolog"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.31557\/APJCP.2020.21.9.2639","article-title":"Cost of treatment for cervical cancer in India","volume":"21","author":"Singh","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"100296","DOI":"10.1016\/j.lansea.2023.100296","article-title":"Survival of patients with cervical cancer in India \u2013 findings from 11 population based cancer registries under National Cancer Registry Programme","volume":"24","author":"Sathishkumar","year":"2023","journal-title":"Lancet Regional Health-Europe"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1574887111666160502160748","article-title":"Development of human papillomavirus (HPV) vaccines: A review of literature and clinical update","volume":"11","author":"Sangar","year":"2016","journal-title":"Rev Recent Clin Trials"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"106399","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Preventive Medicine"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"R29-20260423","first-page":"541","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization","volume":"94","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: A multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol"},{"key":"R31-20260423","first-page":"645","article-title":"Human papillomavirus vaccines: WHO position paper, December 2022","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"394595","DOI":"10.1155\/2014\/394595","article-title":"HPV Vaccination in India: Critical appraisal","volume":"2014","author":"Nigam","year":"2014","journal-title":"ISRN Obstet Gynecol"},{"key":"R33-20260423","doi-asserted-by":"crossref","first-page":"805695","DOI":"10.3389\/fimmu.2021.805695","article-title":"An update on human papilloma virus vaccines: History, types, protection, and efficacy","volume":"12","author":"Yousefi","year":"2022","journal-title":"Front Immunol"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s12889-020-08753-y","article-title":"The quadrivalent HPV vaccine is protective against genital warts: A meta-analysis","volume":"20","author":"Luk\u00e1cs","year":"2020","journal-title":"BMC Public Health"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/vaccines9121413","article-title":"Human papillomavirus vaccine efficacy and effectiveness against cancer","volume":"9","author":"Kamolratanakul","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R37-20260423","first-page":"Cd009069","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiy067","article-title":"High effectiveness of the bivalent human papillomavirus (HPV) vaccine against incident and persistent HPV infections up to 6 years after vaccination in young Dutch women","volume":"217","author":"Donken","year":"2018","journal-title":"J Infect Dis"},{"key":"R39-20260423","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis","volume":"12","author":"Malag\u00f3n","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R40-20260423","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: A randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet"},{"key":"R41-20260423","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1470-2045(23)00480-1","article-title":"Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: A randomised, active-controlled, multicentre, phase 2\/3 trial","volume":"24","author":"Sharma","year":"2023","journal-title":"Lancet Oncol"},{"key":"R42-20260423","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vaccine.2022.11.044","article-title":"Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination","volume":"41","author":"Joshi","year":"2023","journal-title":"Vaccine"},{"key":"R44-20260423","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4161\/hv.29532","article-title":"Sustained efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine: Final analysis of a long-term follow-up study up to 9.4 years post-vaccination","volume":"10","author":"Naud","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R45-20260423","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3947","article-title":"4-Valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents after 10 years","volume":"140","author":"Ferris","year":"2017","journal-title":"Pediatrics"},{"key":"R46-20260423","first-page":"100401.","article-title":"Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries","volume":"23","author":"Kjaer","year":"2020","journal-title":"E Clin Med"},{"key":"R47-20260423","doi-asserted-by":"crossref","first-page":"59","DOI":"10.23736\/S0026-4946.17.05147-7","article-title":"Safety of HPV vaccines in the age of nonavalent vaccination","volume":"70","author":"Quattrone","year":"2018","journal-title":"Minerva Pediatr"},{"key":"R52-20260423","doi-asserted-by":"crossref","first-page":"e0238291","DOI":"10.1371\/journal.pone.0238291","article-title":"Cost effectiveness of strategies for cervical cancer prevention in India","volume":"15","author":"Chauhan","year":"2020","journal-title":"PLoS One"},{"key":"R53-20260423","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajco.13962","article-title":"Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India","volume":"20","author":"Arora","year":"2024","journal-title":"Asia Pac J Clin Oncol"},{"key":"R54-20260423","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vaccine.2019.10.092","article-title":"Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9-25 years: A systematic review and meta-analysis","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"key":"R55-20260423","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4161\/hv.29617","article-title":"Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule","volume":"10","author":"Gilca","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R56-20260423","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4269\/ajtmh.20-1650","article-title":"Challenges to human papillomavirus vaccine acceptability among women in south India: An exploratory study","volume":"105","author":"Shah","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"R57-20260423","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40258-020-00576-7","article-title":"Factors influencing the cost-effectiveness outcomes of HPV vaccination and screening interventions in low-to-middle-income countries (LMICs): A systematic review","volume":"18","author":"Okeah","year":"2020","journal-title":"Appl Health Econ Health Policy"},{"issue":"Suppl 1","key":"R60-20260423","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1016\/j.vaccine.2021.07.024","article-title":"Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019","volume":"40","author":"Ahmed","year":"2022","journal-title":"Vaccine"},{"key":"R63-20260423","doi-asserted-by":"crossref","first-page":"E147.","DOI":"10.1016\/S1470-2045(23)00118-3","article-title":"India rolls out HPV vaccination","volume":"24","author":"Burki","year":"2023","journal-title":"Lancet"},{"key":"R64-20260423","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijgo.14428","article-title":"Prevalence of high-risk HPV among marginalized urban women in India and its implications on vaccination: A cross sectional study","volume":"162","author":"Vora","year":"2023","journal-title":"Int J Gynaecol Obst"},{"key":"R67-20260423","article-title":"Resource stratified guidelines for preventive oncology and primary care","year":"2019","journal-title":"Summary reso"},{"key":"R68-20260423","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5334\/aogh.2735","article-title":"Prevalence of cervical cancer screening and awareness among women in an urban community in south India-A cross sectional study","volume":"86","author":"Reichheld","year":"2020","journal-title":"Ann Glob Health"}],"container-title":["Indian Journal of Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_738_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:16:50Z","timestamp":1787757410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_738_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijcm.ijcm_738_24","relation":{},"ISSN":["0970-0218","1998-3581"],"issn-type":[{"value":"0970-0218","type":"print"},{"value":"1998-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-10-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}